Breaking News

Breaking News
20 February 2012
Cancer risk is increased in patients with chronic urticaria
 
16 February 2012
Blue light improves plaque status in psoriasis vulgaris
 
15 February 2012
Vitamin B deficiency and hyperhomocystinemia may have a common genetic pathway for vitiligo
 
14 February 2012
Younger patients with psoriasis have a higher risk of type 2 diabetes
 
13 February 2012
Practical guideline covers use of wet-wrap treatment in atopic dermatitis in children
 
10 February 2012
Clinical forms of vitiligo and disease-related variables studied in a Brazilian population
 
09 February 2012
Consensus guidelines updated for the management of plaque psoriasis
 
08 February 2012
Narrowband UVB phototherapy associated with improvements in patients with chronic ordinary urticaria (1)
 
07 February 2012
Acyclovir and hydrocortisone cream shows encouraging results in phase III trial in adolescents with recurrent herpes simplex labialis
 
06 February 2012
Case series examines tacrolimus ointment treatment in folliculitis decalvans
 
03 February 2012
A Phase III, randomized, double-blind, controlled trial of briakinumab in moderate-severe psoriasis
 
02 February 2012
Phase II study shows tacrolimus ointment to be efficacious and well tolerated long term in infants with atopic dermatitis
 
01 February 2012
Longer treatment with diclofenac in hyaluronic acid gel does not increase clearance rate of actinic keratoses
 
31 January 2012
Psoriasis is associated with an increased risk of COPD
 
30 January 2012
Teledermatology leads to better outcomes for diagnosis, disease management and to clinical improvement
 
27 January 2012
Fractionated has greater responses than single photodynamic therapy in actinic keratoses
 
26 January 2012
Psoriasis appears to be associated with pregnancy complications
 
25 January 2012
Lactase deficiency may be causal factor in chronic pruritus of unknown origin
 
24 January 2012
Teledermatology shows promise in monitoring patients on biologic therapy for psoriasis
 
23 January 2012
CD10 expression predicts tumor progression and poor prognosis in malignant melanoma